Blepharitis

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Blepharitis Trial in United States (TP-03, 0.25%, TP-03 Vehicle)

Completed
  • Blepharitis
  • TP-03, 0.25%
  • TP-03 Vehicle
  • Phoenix, Arizona
  • +14 more
Jul 7, 2022

Blepharitis Trial in United States (ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined), Azasite, Dexamethasone)

Completed
  • Blepharitis
  • ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
  • +3 more
  • Chandler, Arizona
  • +44 more
Nov 18, 2021

Blepharitis Trial in United States (TP-03, TP-03 Vehicle)

Recruiting
  • Blepharitis
  • Scottsdale, Arizona
  • +20 more
Nov 4, 2021

Blepharitis, Meibomianitis, Dry Eye Trial in United States (COL-101 (doxycycline, USP) capsules, )

Completed
  • Blepharitis
  • +2 more
  • COL-101 (doxycycline, USP) capsules
  • placebo
  • Little Rock, Arkansas
  • +7 more
Feb 16, 2021

Blepharitis, Dry Eye Syndrome Trial in United States (LipiFlow Pre-Treatment, LipiFlow Post-treatment)

Completed
  • Blepharitis
  • Dry Eye Syndrome
  • LipiFlow Pre-Treatment
  • LipiFlow Post-treatment
  • Hoffman Estates, Illinois
  • +6 more
Aug 30, 2018